ArticleInternational journal of medical sciences2021

Comparing mTOR inhibitor Rapamycin with Torin-2 within the RIST molecular-targeted regimen in neuroblastoma cells.

Rebecca Waetzig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.